We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lab Offers New Generation Sequencing Test for Wound Microorganisms

By LabMedica International staff writers
Posted on 06 Jun 2016
DNA sequencing technology underlies a new diagnostic service that claims to identify all bacteria, fungi, and parasites as well as select viruses in a wound or infected area.

The "Wound~Seq" test, which is performed on swab samples taken from the affected area, is available through Granger Diagnostics (Richmond, VA, USA). Samples collected by the doctor are sent to Granger's laboratory, and results are usually returned within 48 hours.

Image: The Wound~Seq test does not rely on bacterial culture, but rather uses state-of-the-art DNA sequencing technology to identify all bacteria present in the wound (Photo courtesy of Granger Diagnostics).
Image: The Wound~Seq test does not rely on bacterial culture, but rather uses state-of-the-art DNA sequencing technology to identify all bacteria present in the wound (Photo courtesy of Granger Diagnostics).

The Wound~Seq assay utilizes state-of-the-art DNA sequencing technology to identify all microorganisms present in the wound and does not rely on culture methods. It is the second Next-Generation Care Test in Granger Diagnostics' pipeline, following Gynecologene, a test for bacterial vaginosis that incorporates this DNA sequencing technology.

Dr. David G. Bostwick, chief medical officer at Granger Diagnostics, said, "We are excited to make available, for the first time, our clinically- significant test, Wound~Seq, that utilizes next-generation sequencing of the skin microbiome. Wounds and infections afflict millions of Americans every year, and are often perplexing to treat owing to the presence of unknown pathogens. Our new validated test provides significant actionable information that assists physicians in managing infections. Previous studies have shown that wound closure that relies on genetic-assisted testing is much more rapid, decreases pain and suffering, and results in cost savings. The promise of personalized medicine is now fulfilled."

Related Links:
Granger Diagnostics

Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Automated Blood Typing System
IH-500 NEXT
New
Auto-Chemistry Analyzer
CS-1200
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR

Latest Microbiology News

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment